# Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.

> **NCT06618989** · — · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 180 (estimated)

## Conditions studied

- Children Under 3 Months of Age With Fever

## Interventions

- **OTHER:** Blood sampling and follow-up call

## Key facts

- **NCT ID:** NCT06618989
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-24
- **Primary completion:** 2027-08-24
- **Final completion:** 2027-09-07
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618989, "Diagnostic Performance of a Combination of Leukocyte Cell Surface Markers in Predicting the Risk of Severe Bacterial Infection in Febrile Children Under Three Months of Age in the Emergency Department: a Pilot Study.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06618989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*